Steve K. Teo

817 total citations
18 papers, 634 citations indexed

About

Steve K. Teo is a scholar working on Hematology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Steve K. Teo has authored 18 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Psychiatry and Mental health. Recurrent topics in Steve K. Teo's work include Multiple Myeloma Research and Treatments (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Steve K. Teo is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Steve K. Teo collaborates with scholars based in Switzerland, United States and United Kingdom. Steve K. Teo's co-authors include Steve D. Thomas, David Stirling, Karin A. Kook, Wayne A. Colburn, Vikram Khetani, William Tracewell, Katherine O’Brien, Oscar L. Laskin, Alan M. Hoberman and Patrick J. Sabourin and has published in prestigious journals such as Toxicological Sciences, Clinical Pharmacokinetics and Pharmacology Biochemistry and Behavior.

In The Last Decade

Steve K. Teo

18 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve K. Teo Switzerland 16 262 202 121 119 63 18 634
Stefaan Rossenu Belgium 19 126 0.5× 153 0.8× 201 1.7× 117 1.0× 40 0.6× 35 976
Patricia Schroeder United States 18 111 0.4× 261 1.3× 28 0.2× 153 1.3× 153 2.4× 35 867
Evelyn D. Lobo United States 14 57 0.2× 426 2.1× 181 1.5× 239 2.0× 69 1.1× 26 1.4k
Theresa A. Davies United States 14 78 0.3× 212 1.0× 62 0.5× 35 0.3× 17 0.3× 27 726
Tim Ibbotson United Kingdom 14 46 0.2× 160 0.8× 174 1.4× 69 0.6× 17 0.3× 23 737
Mark G. Eller United States 17 83 0.3× 208 1.0× 35 0.3× 69 0.6× 16 0.3× 34 749
Jeroen C. G. den Burger Netherlands 11 136 0.5× 151 0.7× 67 0.6× 76 0.6× 35 0.6× 11 724
Arno Sinjewel Netherlands 11 77 0.3× 105 0.5× 68 0.6× 48 0.4× 23 0.4× 13 456
A. Dvilansky Israel 13 133 0.5× 163 0.8× 27 0.2× 24 0.2× 52 0.8× 60 533
Jean‐Michel Scherrmann France 16 35 0.1× 339 1.7× 47 0.4× 387 3.3× 60 1.0× 27 968

Countries citing papers authored by Steve K. Teo

Since Specialization
Citations

This map shows the geographic impact of Steve K. Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve K. Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve K. Teo more than expected).

Fields of papers citing papers by Steve K. Teo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve K. Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve K. Teo. The network helps show where Steve K. Teo may publish in the future.

Co-authorship network of co-authors of Steve K. Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Steve K. Teo. A scholar is included among the top collaborators of Steve K. Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve K. Teo. Steve K. Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Teo, Steve K., et al.. (2004). A Single‐Dose, Two‐Way Crossover, Bioequivalence Study of Dexmethylphenidate HCl with and without Food in Healthy Subjects. The Journal of Clinical Pharmacology. 44(2). 173–178. 15 indexed citations
2.
Teo, Steve K., Wayne A. Colburn, William Tracewell, et al.. (2004). Clinical Pharmacokinetics of Thalidomide. Clinical Pharmacokinetics. 43(5). 311–327. 108 indexed citations
3.
Teo, Steve K., et al.. (2004). Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits. Birth Defects Research Part B Developmental and Reproductive Toxicology. 71(1). 1–16. 16 indexed citations
4.
Teo, Steve K.. (2004). Effects of Thalidomide on Developmental, Peri- and Postnatal Function in Female New Zealand White Rabbits and Offspring. Toxicological Sciences. 81(2). 379–389. 14 indexed citations
5.
Teo, Steve K., David Stirling, Steve D. Thomas, & Vikram Khetani. (2003). Neurobehavioral effects of racemic threo-methylphenidate and its d and l enantiomers in rats. Pharmacology Biochemistry and Behavior. 74(3). 747–754. 28 indexed citations
6.
Teo, Steve K., Yong Chen, George W. Muller, et al.. (2003). Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and phosphate‐buffered saline. Chirality. 15(4). 348–351. 23 indexed citations
7.
Teo, Steve K., David Stirling, Alan M. Hoberman, et al.. (2003). D‐methylphenidate and D,L‐methylphenidate are not developmental toxicants in rats and rabbits. Birth Defects Research Part B Developmental and Reproductive Toxicology. 68(2). 162–171. 28 indexed citations
8.
Teo, Steve K., Richard H.C. San, Ramadevi Gudi, et al.. (2003). d-Methylphenidate is non-genotoxic in in vitro and in vivo assays. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 537(1). 67–79. 29 indexed citations
9.
Teo, Steve K., David Stirling, Steve D. Thomas, Mark G. Evans, & Vikram Khetani. (2003). A 90-Day Oral Gavage Toxicity Study of d-Methylphenidate and d, I-Methylphenidate in Beagle Dogs. International Journal of Toxicology. 22(3). 215–226. 18 indexed citations
10.
Teo, Steve K., et al.. (2002). Thalidomide in the treatment of leprosy. Microbes and Infection. 4(11). 1193–1202. 105 indexed citations
11.
12.
Teo, Steve K., David Stirling, Steve D. Thomas, et al.. (2002). The perinatal and postnatal toxicity of d-methylphenidate and d,l-methylphenidate in rats. Reproductive Toxicology. 16(4). 353–366. 28 indexed citations
13.
Teo, Steve K., Karin A. Kook, William Tracewell, et al.. (2001). Thalidomide Dose Proportionality Assessment following Single Doses to Healthy Subjects. The Journal of Clinical Pharmacology. 41(6). 662–667. 25 indexed citations
14.
Teo, Steve K., Faruq H. Noormohamed, Mike Youle, et al.. (2001). Thalidomide is distributed into human semen after oral dosing.. PubMed. 29(10). 1355–7. 42 indexed citations
15.
Teo, Steve K., Patrick J. Sabourin, Katherine O’Brien, Karin A. Kook, & Steve D. Thomas. (2000). Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen?s disease patients. Journal of Biochemical and Molecular Toxicology. 14(3). 140–147. 58 indexed citations
16.
Teo, Steve K., Karin A. Kook, William Tracewell, et al.. (2000). Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women. Biopharmaceutics & Drug Disposition. 21(1). 33–40. 23 indexed citations
17.
Teo, Steve K., Wayne A. Colburn, & Steve D. Thomas. (1999). Single‐Dose Oral Pharmacokinetics of Three Formulations of Thalidomide in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 39(11). 1162–1168. 46 indexed citations
18.
Teo, Steve K., et al.. (1999). Subchronic Toxicity of Thalidomide in Rodents After 13 Weeks of Oral Administration. International Journal of Toxicology. 18(5). 337–352. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefaan Rossenu Breakdown of academic impact, for papers by Patricia Schroeder Breakdown of academic impact, for papers by Evelyn D. Lobo Breakdown of academic impact, for papers by Theresa A. Davies Breakdown of academic impact, for papers by Tim Ibbotson Breakdown of academic impact, for papers by Mark G. Eller Breakdown of academic impact, for papers by Jeroen C. G. den Burger Breakdown of academic impact, for papers by Arno Sinjewel Breakdown of academic impact, for papers by A. Dvilansky Breakdown of academic impact, for papers by Jean‐Michel Scherrmann
Rankless by CCL
2026